| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08313 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20811 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08940 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41099-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72221 | |||
![Immunohistochemistry-Paraffin: Bcl-6 Antibody (BCL6/2497R) [NBP3-07563] - Formalin-fixed, paraffin-embedded human Tonsil stained with Bcl-6 Rabbit Recombinant Monoclonal Antibody (BCL6/2497R).](http://images.novusbio.com/fullsize/Bcl-6-Antibody-BCL6-2497R-Immunohistochemistry-Paraffin-NBP3-07563-img0001.jpg "Immunohistochemistry-Paraffin: Bcl-6 Antibody (BCL6/2497R) [NBP3-07563] - Formalin-fixed, paraffin-embedded human Tonsil stained with Bcl-6 Rabbit Recombinant Monoclonal Antibody (BCL6/2497R).")
![A431 whole cell and nuclear extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with SA1 antibody [HL3139] (NBP3-48769) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp3-48769_rabbit-sa1-mab-hl3139-western-blot-1411202518433311.jpg "<b>Orthogonal Strategies Validation. </b>A431 whole cell and nuclear extracts (30 ug) were separated by 5% SDS-PAGE, and the membrane was blotted with SA1 antibody [HL3139] (NBP3-48769) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.")
![Western Blot: CDC25C [p Ser216] Antibody [NBP3-12879] - Untreated (-) and treated (+) HeLa whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with CDC25C (phospho Ser216) antibody (NBP3-12879) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/CDC25C-[p-Ser216]-Antibody-Western-Blot-NBP3-12879-img0001.jpg "<b>Biological Strategies Validation. </b>Western Blot: CDC25C [p Ser216] Antibody [NBP3-12879] - Untreated (-) and treated (+) HeLa whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with CDC25C (phospho Ser216) antibody (NBP3-12879) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![Immunohistochemistry-Paraffin: RB1 Antibody (RB1/2313R) [NBP3-07196] - Formalin-fixed, paraffin-embedded human Colon Carcinoma stained with RB1 Recombinant Rabbit Monoclonal Antibody (RB1/2313R).](http://images.novusbio.com/fullsize/RB1-Antibody-RB1-2313R-Immunohistochemistry-Paraffin-NBP3-07196-img0001.jpg "Immunohistochemistry-Paraffin: RB1 Antibody (RB1/2313R) [NBP3-07196] - Formalin-fixed, paraffin-embedded human Colon Carcinoma stained with RB1 Recombinant Rabbit Monoclonal Antibody (RB1/2313R).")
![Immunohistochemistry: LZTS2 Antibody [NBP2-41099] - Immunohistochemistry of LZTS2 in human placenta tissue with LZTS2 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/LZTS2-Antibody-Immunohistochemistry-NBP2-41099-img0001.jpg "Immunohistochemistry: LZTS2 Antibody [NBP2-41099] - Immunohistochemistry of LZTS2 in human placenta tissue with LZTS2 antibody at 5 ug/mL.")
![Western Blot: CEP63 Antibody (OTI2H2) [NBP2-46242] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEP63 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CEP63.](http://images.novusbio.com/fullsize/CEP63-Antibody-OTI2H2-Western-Blot-NBP2-46242-img0001.jpg "Western Blot: CEP63 Antibody (OTI2H2) [NBP2-46242] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEP63 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CEP63.")
![Western Blot: CCNB3 Antibody [NBP1-80384] - Human Muscle lysate, concentration 0.2-1 ug/ml.](http://images.novusbio.com/fullsize/CCNB3-Antibody-Western-Blot-NBP1-80384-img0002.jpg "Western Blot: CCNB3 Antibody [NBP1-80384] - Human Muscle lysate, concentration 0.2-1 ug/ml.")
![Western Blot: NUBP1 Antibody [NBP1-57039] - Titration: 0.2-1 ug/ml, Positive Control: U937 cell lysate.](http://images.novusbio.com/fullsize/NUBP1-Antibody-Western-Blot-NBP1-57039-img0003.jpg "Western Blot: NUBP1 Antibody [NBP1-57039] - Titration: 0.2-1 ug/ml, Positive Control: U937 cell lysate.")
![Western Blot: SMC2 Antibody [NBP1-52932] - 293T cells lysate, concentration 0.2-1 ug/ml.](http://images.novusbio.com/fullsize/SMC2-Antibody-Western-Blot-NBP1-52932-img0002.jpg "Western Blot: SMC2 Antibody [NBP1-52932] - 293T cells lysate, concentration 0.2-1 ug/ml.")
![Western Blot: CDCA5 Antibody [NBP1-55143] - OVCAR-3 cell lysate, concentration 0.2-1 ug/ml.](http://images.novusbio.com/fullsize/CDCA5-Antibody-Western-Blot-NBP1-55143-img0002.jpg "Western Blot: CDCA5 Antibody [NBP1-55143] - OVCAR-3 cell lysate, concentration 0.2-1 ug/ml.")
![Western Blot: CDCA5 Antibody [NBP1-55144] - Titration: 0.2-1 ug/ml, Positive Control: Human Placenta.](http://images.novusbio.com/fullsize/CDCA5-Antibody-Western-Blot-NBP1-55144-img0003.jpg "Western Blot: CDCA5 Antibody [NBP1-55144] - Titration: 0.2-1 ug/ml, Positive Control: Human Placenta.")